Beyond the Scale: Rutgers Study Links GLP-1 Medications to Reductions in Violent Impulses
Comments Off on Beyond the Scale: Rutgers Study Links GLP-1 Medications to Reductions in Violent Impulses
June 18, 2026
Popular GLP-1 receptor agonists—most notably Ozempic and Wegovy—have fundamentally reshaped the landscape of metabolic medicine. Initially approved for the management of type 2 diabetes and subsequently heralded as a breakthrough in obesity treatment,…
